🚨🚨Paper out! 🚨🚨
Delighted to share our work, now published in @NatureGenet 🧬! https://t.co/7KJpQBsLWq
We identified a targetable, chromothripsis-associated genetic event in blast phase (BP) MPN, a particularly poor prognostic subtype of acute leukaemia. 1/n
🧵👇
This field is so very special - it truly feels like a family. Thank you #MPNfriends for taking me in, fostering my career development, and being such wonderful friends and colleagues. Thank you @ESHaematology for a fantastic and meeting. Obrigato Portugal for being so welcoming!
Terrific Ernest Beutler honorific lecture session #ASH25 by @mpdrc and Radek Skoda on discovery of JAK mutations and development of JAK inhibitors. Generous to collaborators in the #MPNsm community and key role of patients, very classy. And the room was such lurid green ala #Wicked that I was waiting for someone to start soaring around on a broom and singing “Defying Gravity”! 🧙 🤪
Huge congratulations to Amir Fathi for delivering one of the most impactful plenary presentations @ASH_hematology in AML in past decade. The PARADIGM study may lead to a Paradigm shift- Aza/Ven > intensive chemo in newly Dx high-risk AML. 👏👏👏
Fantastic discussion from Adam Meade, @CKBrierley & Juan Carlos Hernandez-Boluda who covered novel ideas on blastic phase and transplantation #iwMDSMPN25 🩸 📷
Full discussion will be posted soon on https://t.co/O9p0vDBrzw 📷
🚨🚨Paper out! 🚨🚨
Delighted to share our work, now published in @NatureGenet 🧬! https://t.co/7KJpQBsLWq
We identified a targetable, chromothripsis-associated genetic event in blast phase (BP) MPN, a particularly poor prognostic subtype of acute leukaemia. 1/n
🧵👇